In preclinical and clinical studies at cytostatic doses, paclitaxel has demonstrated promising results for reducing the processes leading to restenosis. |
Paclitaxel is the world's largest selling antineoplastic drug. |
The drug, Paclitaxel, is meant to prevent restenosis, the narrowing of the arterial walls after a stent is inserted to unblock an artery. |
Standard dosages of paclitaxel and carboplatin will be delivered with escalating dosages of REOLYSIN intravenously. |
The newest stents are made of metal coated with a cytostatic agent such as sirolimus or paclitaxel. |
Other commonly used drugs are gemcitabine, paclitaxel, docetaxel, pemetrexed, etoposide or vinorelbine. |